Cathepsin D—many functions of one aspartic protease P Benes, V Vetvicka, M Fusek Critical reviews in oncology/hematology 68 (1), 12-28, 2008 | 765 | 2008 |
Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the … V Vetvicka, BP Thornton, GD Ross The Journal of clinical investigation 98 (1), 50-61, 1996 | 552 | 1996 |
β-Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action M Novak, V Vetvicka Journal of immunotoxicology 5 (1), 47-57, 2008 | 462 | 2008 |
The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b … Y Xia, V Vetvicka, J Yan, M Hanikýřová, T Mayadas, GD Ross The Journal of Immunology 162 (4), 2281-2290, 1999 | 407 | 1999 |
β-Glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18) J Yan, V Větvička, Y Xia, A Coxon, MC Carroll, TN Mayadas, GD Ross The Journal of Immunology 163 (6), 3045-3052, 1999 | 252 | 1999 |
Glucans as biological response modifiers M Novak, V Vetvicka Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2009 | 230 | 2009 |
Effects of marine β− 1, 3 glucan on immune reactions V Vetvicka, JC Yvin International immunopharmacology 4 (6), 721-730, 2004 | 229 | 2004 |
Biocompatibility of N-(2-Hydroxypropyl) methacrylamide copolymers containing adriamycin: Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and … B Rihova, M Bilej, V Vetvicka, K Ulbrich, J Strohalm, J Kopecek, R Duncan Biomaterials 10 (5), 335-342, 1989 | 225 | 1989 |
Beta glucan: supplement or drug? From laboratory to clinical trials V Vetvicka, L Vannucci, P Sima, J Richter Molecules 24 (7), 1251, 2019 | 207 | 2019 |
β-glucans and cholesterol P Sima, L Vannucci, V Vetvicka International journal of molecular medicine 41 (4), 1799-1808, 2018 | 192 | 2018 |
Orally administered marine (1→ 3)-β-d-glucan Phycarine stimulates both humoral and cellular immunity V Vetvicka, B Dvorak, J Vetvickova, J Richter, J Krizan, P Sima, JC Yvin International journal of biological macromolecules 40 (4), 291-298, 2007 | 178 | 2007 |
Molecular interactions of β-(1→ 3)-glucans with their receptors L Legentil, F Paris, C Ballet, S Trouvelot, X Daire, V Vetvicka, V Ferrières Molecules 20 (6), 9745-9766, 2015 | 172 | 2015 |
Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives V Vetvicka, AS Laganà, FM Salmeri, O Triolo, VI Palmara, SG Vitale, ... Archives of gynecology and obstetrics 294, 897-904, 2016 | 165 | 2016 |
Immunological aspects of endometriosis: a review M Králíčková, V Vetvicka Annals of translational medicine 3 (11), 2015 | 159 | 2015 |
The effects of β–glucan on fish immunity V Vetvicka, L Vannucci, P Sima North American journal of medical sciences 5 (10), 580, 2013 | 149 | 2013 |
Mitogenic function of human procathepsin D: the role of the propeptide M Fusek, V Vetvicka Biochemical Journal 303 (3), 775-780, 1994 | 148 | 1994 |
Glucan-immunostimulant, adjuvant, potential drug V Vetvicka World journal of clinical oncology 2 (2), 115, 2011 | 132 | 2011 |
Pilot study: orally-administered yeast β1, 3-glucan prophylactically protects against anthrax infection and cancer in mice V Vetvicka J. Am. Nutraceut. Assn. 5, 16-20, 2002 | 128 | 2002 |
Endometriosis and risk of ovarian cancer: what do we know? M Králíčková, AS Laganà, F Ghezzi, V Vetvicka Archives of gynecology and obstetrics 301, 1-10, 2020 | 127 | 2020 |
Dual role of cathepsin D: ligand and protease M Fusek, V Vetvicka Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 (1), 43-50, 2005 | 120 | 2005 |